Trials / Completed
CompletedNCT00184613
Comparison of Insulin Glargine Against Insulin Aspart Infused Under the Skin in Patients With Type 2 Diabetes
An Open-label, Randomised, In-patient, Cross Over PK/PD Trial Investigating the Pharmackinectic and Pharmacodynamic Profiles Following Continuous Subcutaneous Infusion of Insulin Aspart or Injection of Insulin Glargine in Subjects With Type 2 Diabetes Mellitus
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- Novo Nordisk A/S · Industry
- Sex
- All
- Age
- 30 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This trial is conducted in Europe. The objective of the study is to investigate the effect and safety of continously basal delivered insulin aspart given by a pump versus once daily injection of insulin glargine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | pump | |
| DRUG | insulin glargine | |
| DRUG | insulin aspart |
Timeline
- Start date
- 2005-05-01
- Primary completion
- 2006-01-01
- Completion
- 2006-01-01
- First posted
- 2005-09-16
- Last updated
- 2016-10-17
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT00184613. Inclusion in this directory is not an endorsement.